Clondalkin Pharma & Healthcare invests in serialisation technology

Installs Atlantic Zeiser Digiline 300 at its Cherry Orchard facility in Dublin, Ireland

Clondalkin adds a serialisation capability at one of its facilities in Ireland

The installation of an Atlantic Zeiser Digiline 300 at Clondalkin's facility in Dublin has introduced a track and trace capability for new serialisation standards.

The investment will support track and trace capability for product movement as well as provide authentication, improved brand protection and increased consumer confidence, the packaging specialist said.

The finished cartons are fed into a coding stream that utilises a printhead and UV dryer allowing fast coding speeds, while the twin vericam camera data inspection system verifies application. An automated rejection process is also included.

Mark Rooney, COO for Clondalkin Pharma & Healthcare Specialist Packaging Division (SPD) highlighted the flexible nature of the equipment: 'Many pharmaceutical companies are responding to the challenge of serialisation standards by upgrading or installing lines capable of applying a track and trace identifier, but this is often confined to 2D barcoding and batch specific data,' he said.

'We have the capability to individually code products of various sizes including flat cartons both glued and unglued. The system can receive and manage multiple data files and print multiple code. The wide print head with multiple image print capability in direction of feed allows 2D matrix and code 128 possible in separate locations once within same print width profile. Should the need occur additional print heads can be added to extend the print location capability. The two separate camera verification scanning units ensure quality of code read and verification of code, or multiple code to the master input data.'

Since the installation of the equipment Clondalkin has been approached by several pharmaceutical companies that have identified it as a good fit to their in house capability and avoids costly line reconfiguration and downtime.

From its three facilities in Ireland, Clondalkin Pharma & Healthcare produces cartons, labels and leaflets to clinical trial extended content labels to customers across Ireland, the UK , Europe and the US.

Globally Clondalkin Group's Specialist Packaging Division has 24 production sites throughout North America and Europe and includes folding cartons, labels, leaflets, literature and inserts/outserts businesses, along with paper packaging and printing components. It operates across an extensive range of markets including pharmaceuticals, cosmetics, toiletries and confectionery.

Companies